Loading data for PLRX — first visit, this takes a few seconds.
Pliant Therapeutics Inc. (PLRX)
NasdaqGS: PLRX
· Real-Time Price · USD
1.19
+0.05 (4.39%)
At close: Aug 25, 2026, 3:59 PM
1.19
+0.00%
After-hours: 7:30 PM
The price, the headline numbers and the latest news, in one place.
Pliant Therapeutics Inc. (PLRX) Stock Price, Analysis & Data
4.39% (1D)
| Bid | 0.85 |
| Market Cap | 73.69M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -92.29M |
| 1.27 | |
| -1.5 | |
| n/a | |
| -0.89 | |
| P/B (ttm) | 0.50 |
| P/S (ttm) | n/a |
| Earnings Date | Nov 5, 2026 |
| Ask | 1.48 |
| Volume | 321,922 |
| Avg. Volume (20D) | 527,019 |
| Open | 1.14 |
| Previous Close | 1.14 |
| Day's Range | 1.13 - 1.19 |
| 52-Week Range | 1.02 - 1.95 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About PLRX
Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integr...
Industry Biotechnology
Sector Healthcare
IPO Date Jun 3, 2020
Employees 49
Stock Exchange NasdaqGS
Ticker Symbol PLRX
Website https://pliantrx.com
Financial Performance
In 2025, Pliant Therapeutics's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -149.34M, a decrease of -28.99%.
Financial StatementsEarnings Surprise
Pliant Therapeutics has released their quarterly earnings on Aug 11, 2026:
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of -0.36 misses estimates by -0.02, with 49.30% YoY growth.
Pliant Therapeutics Inc. is scheduled to release its earnings on Nov 5, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
